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Summary: Narcolepsy runs in families, and recent research has revealed the 
human leukocyte antigen (HLA) DR2 to be a genetic marker closely associated 
with the disease. But, as indicated by family studies, other factors contribute 
to the pathogenesis of narcolepsy. The investigation of monozygotic twins is 
the most specific research tool for distinguishing between a multigenetic and a 
multifactorial pathogenetic model. We present clinical and sleep polygraphic 
data from two pairs of monozygotic twins, and in addition, from some oftheir 
first-degree relatives. In both pairs only one twin suffered from the clinical 
symptoms of narcolepsy/cataplexy. Only in these subjects did night sleep re-
cordings and a multiple sleep latency test reveal both multiple sleep onset 
rapid-eye-movement periods (SOREMPs) and short mean sleep onset laten-
cies. However, in two of the asymptomatic, HLA DR2 + relatives, short mean 
sleep onset latencies during the mUltiple sleep latency test (MSL T) were ob-
served, and one, HLA DR2 - relative showed REM sleep two times during the 
MSLT. Our results strongly favor a multifactorial pathogenetic model for nar-
colepsy. Key Words: Narcolepsy-Genetics-Sleep disorders-Familial. 
The nearly perfect association between narcolepsy and the human leukocyte antigen 
(HLA) DR2 (1,2) confirmed the long-standing assumption that genetic factors are in-
volved in the pathogenesis of the disease (3-6). While -99% of all narcoleptic patients 
studied turned out to be DR2 + , the percentage is only 30-35% in the general population 
(7). Thus, the presence of the HLA-DR2 or an adjacent gene seems to be involved in 
the development of the illness. Since 50% of the first-degree relatives of a patient share 
with him the critical gene, but only 5% develop the disease (5), one has to assume that 
other genetic and/or environmental factors are necessary for the development of nar-
colepsy. 
The investigation of monozygotic twins is at present the most specific research tool 
to distinguish between a multigenetic and a multifactorial pathogenetic model, whereby 
the latter postulates the synergistic effect of at least one genetic and one environmental 
factor. 
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Due to the low prevalence of the disease, there are few reports on narcolepsy in 
monozygotic twins in the literature. Until now only one pair could be demonstrated to 
be concordant according to clinical and polygraphical criteria (8). These twins were 
HLA DR2-. In the twins reported to be concordant by Imlah (9), clinical diagnosis is 
doubtful in both twins. Sleep attacks were atypical and cataplectic attacks were not 
provoked by emotions; polygraphic sleep recordings were not performed. One of the 
twins claimed to be concordant for narcolepsy by Mamelak et al. (10) suffered only 
from mild daytime drowsiness and fatigue at the time of investigation. No sleep abnor-
mality was obvious during a 48-h polygraphic recording. Some years before, however, 
clinical symptoms including cataplexy were present. Schrader et al. (11), Montplaisir 
and Poirier (12), and Guilleminault et al. (13) all reported monozygotic twins discordant 
for narcolepsy according to clinical and polygraphical criteria. 
Recently we had the opportunity to investigate two pairs of monozygotic twins by 
means of polygraphic night sleep recordings and the multiple sleep latency test 
(MSLT). In each pair only one twin suffered from the clinical symptoms of narcolepsy. 
In addition, the parents of one pair and a sister of the other were studied with the same 
protocol. All of these relatives were free of narcoleptic symptoms. 
METHODS 
The pedigrees including the first-degree relatives of the twins are given in Fig. 1. In 
family A the twins (AITl and AlT2, 50 years) and one sister (AJS, 44 years) took part 
in our investigation. Their mother (AJM, 82 years) had HLA typing, but polygraphic 
sleep recording could not be performed. In family B the twins (BrTl and BrT2, 20 
years), their father (BIF, 44 years) and their mother (BIM, 39 years) were investigated. 
In all subjects HLA typing was done using standard methods. In the twins, 28 blood 
group systems were determined additionally in order to confirm monozygoticity. 
All subjects (except AJM) slept for two consecutive nights in the sleep laboratory. 
Polygraphic sleep recording [electroencephalogram (EEG), electrooculogram (EOG), 
Pedigree family A Pedigree family B 
B/F (1943) B/M (1948) 
(1939) (1940) AIS (1942) BIll (1967) B/12 
(1980) (1970) (1971) (1974) 
FIG. 1. Pedigrees of the families investigated. All first-degree relatives of the twins are represented. Figures 
in parentheses indicate year of birth. Subjects investigated are marked by the code used in the text. Filled 
symbols represent subjects suffering from clearcut narcolepsy/cataplexy. Hatched symbols represent sub-
jects with a probable diagnosis of narcolepsy. 
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and electromyogram (EMG)] was performed and scored according to standard criteria. 
The parameters common in sleep iesearch were computed (see Results). 
On the day following one of the night sleep recordings an MSLT was performed in all 
subjects except AIM. The original procedure (14) was slightly modified (15). The sub-
jects went to bed every 2 h five times per day beginning at 9:00 a.m. and were instructed 
to sleep; polygraphic recording was finished 30 min later, irrespective whether they 
slept or not. Sleep latency and REM latency were determined according to standard 
criteria (16). 
RESULTS 
Clinical findings 
If not stated otherwise, medical history was uneventful and physical examination did 
not reveal any abnormality in all subjects. 
Family A. Affl was the first born twin. He experienced daytime sleepiness for the 
first time at the age of 12. At the age of 16, he was confined to bed for about 2 weeks 
because he suffered from severe parotitis epidemica. Nothing is known about concom-
itant encephalitis. Immediately thereafter, irresistable sleep attacks, hypnagocic hallu-
cinations, sleep paralysis, and cataplexy, typically provoked by emotions, appeared. At 
the time of investigation, drowsiness occurred about three times a day in quite regular 
intervals. Sleep attacks could be controlled effectively by a planned nap. Cataplectic 
attacks were provoked only when the patient was telling a joke; muscle weakness was 
confined to the face and to the speech muscles. Hypnagogic hallucinations occurred 
two to three times a week. Sleep paralysis very rarely occurred at the time of sleep 
onset. Automatic behavior was not reported. Night sleep was characterized subjec-
tively by a very short sleep onset latency and difficulties in maintaining sleep. To 
control daytime sleepiness Affl was using fenityllin irregularily for 25 years with a 
maximum dosage of 50 mg per day. He had never used anticataplectic drugs (tricyclic 
antidepressants or MAO-inhibitors). Medication was discontinued 1 week before the 
investigation. 
A!f2, the second born twin, had no history of sleep attacks, cataplexy, hypnagocic 
hallucinations, sleep paralysis, or automatic behavior. He described himself as a very 
good sleeper. Subjectively, sleep latency was very short, and sleep was undisturbed 
and refreshing. During the day he would take a nap of -20 min almost every day around 
noon, and sometimes a second short nap in the late afternoon. At the age of 36 A!f2 was 
confined to bed for 1 week due to parotitis epidemica. 
A/S, the sister of the twins, did not report any narcoleptic symptoms. Her sleep 
habits were as follows. She subjectively reported sleep latency to be short, and sleep 
was refreshing and of good quality. Since the age of 40 she awoke normally at about 
3:00 a.m., remained awake for about half an hour and then returned back to sleep 
without problems. She took a nap of -20 min around noon, but did not suffer from 
excessive daytime sleepiness if she skipped the nap. 
AIM, the mother of the twins, could not be seen at our sleep laboratory. All family 
members reported that she had suffered from sleep attacks and cataplexy since her 
youth. 
In summary, one of the twins in family A (Affl) suffered from clearcut narcolepsy/ 
cataplexy according to clinical criteria, whereby the full picture appeared after a par-
otitis epidemica. In addition, it is probable that the mother of the twins also suffered 
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from narcolepsy/cataplexy. The sister investigated did not complain of any symptom of 
narcolepsy, and there was no other known family member afflicted with the disease. 
Family B. Brrl, the first born twin, first experienced excessive daytime sleepiness at 
the age of 15. Since that time imperative sleep attacks and automatic behavior oc-
curred. At the age of 17 he experienced a cataplectic attack for the first time. Cataplexy 
was triggered by emotions and confined to the muscles of the knees and the arms. The 
attacks occurred about once a week. He suffered from hypnagogic hallucinations only 
during a treatment trial with gamma-hydroxy-butyrate, which he took for -1 month at 
the age of 15. Sleep paralysis never occurred. Night sleep was characterized subjec-
tively by a very short sleep onset latency and disturbed sleep continuity. Medication 
with mazindol was discontinued 1 week before the investigation. Brrl in addition 
suffered from mild allergic asthma, which never required drug treatment. 
Brr2, the second born twin, did not complain of any symptom of narcolepsy. He 
usually did not nap during the day. Reported sleep onset latency was -30 min, and 
night sleep was undisturbed and refreshing. He too suffered from allergic asthma, but 
more severely than his twin brother. He took 600 mg of theophylline in the evening and 
fenoterol spray two to four times a day. This medication could not be stopped during 
the investigation. 
B/F, the father of the twins, did not complain of any symptom of narcolepsy. He took 
a planned nap of 1 hour every day in the afternoon. Night sleep was subjectively 
undisturbed and refreshing. 
B/M, the mother of the twins, did not complain of narcoleptic symptoms. She usually 
did not nap during the day, and night sleep was undisturbed and refreshing. 
In summary, one of the twins in family B (BIT!) suffered from clearcut narcolepsy/ 
cataplexy according to clinical criteria. The first-degree relatives investigated were 
asymptomatic and there was no other known family member suffering from narcolepsy. 
HLA typing, blood group testing 
The results of the HLA typing are summarized in Table 1. In both families the twins 
were HLA identical and HLA-DR2+. In addition, subject A/S was HLA identical to her 
brothers. Table 2 shows the results of blood group testing in the twins. All results were 
TABLE 1. HLA phenotypes 
Family A 
AffI;Aff2 Al B8 Cw7 DR3 DRw52 DQw2 
A3 Bw57 Cw6 DR2 DQwI 
AlS Al B8 Cw7 DR3 DRw52 DQw2 
A3 Bw57 Cw6 DR2 DQwI 
AIM A3 Bw57 Cw6 DR2 DQwl 
A2 DR4 DRw53 DQw3 
Family B 
BffI;Bff2 Al B8 DR3 DRw52 DQw2 
A24 Bw57 Cw6 DR2 DQwI 
BIF Al B8 DR3 DRw52 DQw2 
A3 B7 Cw7 DRI DQwl 
BIM A3 B7 Cw7 DQwI 
A24 Bw57 Cw6 DR2 DQwl 
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TABLE 2. Results 0/ blood group testing 
Marker AffI;T2 Brrt;T2 Marker AffI;T2 Brrl;T2 
ABO Al 0 AK I I 
MNSs NSs MSs ADA I I 
Rh CeD.ee CeD.ee 6-PGD A A 
Cw GPT 2-1 2 
K kk kk EsD 2-1 2-1 
Fy a+b- a+b+ GLO I 2 
Jk a-b+ a+b+ Gt I 2-1 
Lu a-b+ a-b+ C3 S S 
Hp I-I 2-1 Tf C2-1 C2-1 
Ge 2-IS IF-IS Bf S S 
Gm 1-2-10+ 1+2-10- PI MI MI 
Km 1+ 1- PIG 2-1 2-1 
aeP B AB F-XIIIB 3-1 3-1 
PGMI 1+1+ 1-2- A2-HS 2-1 2-1 
identical for the respective twin pairs. For family A the probability for the twins to be 
monozygotic is 0.99999, for family B the probability is 0.999994. 
Polygraphic night sleep recordings 
The results of the polygraphic night sleep recordings are given in Table 3. In family A 
the narcoleptic twin (AJTl) showed a short sleep onset latency (SOL) in the second 
night, low sleep efficiency, high percentages of stage 1 sleep and wake, and a very low 
percentage of sleep stages 3 and 4 in both nights. During night 1 a sleep onset REM 
period (SOREMP) was observed. His healthy twin brother (AJT2) showed a high per-
centage of stage 1 sleep and an absence of sleep stages 3 and 4 during both nights. The 
sister (AlS) did show a short SOL in the second night; in all other aspects her sleep was 
normal. 
In family B the narcoleptic twin (Bff2) showed a short SOL in the second night and 
SOREMPs during both nights. Percent stage 1 sleep was high in both nights. In his twin 
TABLE 3. Results o/polygraphic night sleep recordings 
AIr I Aff2 AJS Bffl Bff2 BfM BIF 
Subject I" 2 2 2 2 
TIB (min) 484.5 474.0 479.5 478.5 473.0 474.5 484.5 479.5 484.5 480.0 460.0 479.5 480.5 
SPT (min) 470.5 453.5 472.0 469.0 461.5 472.5 477.5 460.0 471.0 471.5 442.0 468.0 472.5 
SEI (% of SPT) 64.4 76.5 91.5 95.0 91.4 96.4 96.6 97.6 98.0 96.9 96.7 94.4 96.3 
N of awakenings 32 40 40 22 18 12 10 8 10 6 13 22 13 
SOL (min) 14.0 2.0 7.5 9.5 11.5 2.0 7.0 3.5 13.5 8.5 18.0 11.5 7.5 
REM latency (min) 0.0 194.5 139.0 106.5 88.0 91.5 0.0 0.0 160.5 48.5 80.0 46.5 52.0 
Stage % of SPT 
Awake 35.6 23.5 8.5 5.0 8.6 3.6 3.4 2.4 2.0 3.1 3.3 5.6 3.7 
REM 7.0 9.3 14.6 14.1 19.7 24.2 21.9 14.5 18.0 27.1 15.6 18.9 17.8 
I 16.6 12.7 28.0 24.4 7.3 5.7 15.5 20.3 7.4 11.9 13.6 12.3 13.7 
2 40.2 53.1 48.8 56.5 52.8 53.2 39.7 37.6 57.4 38.4 61.2 61.2 56.7 
3 0.2 1.1 0.0 0.0 10.1 9.7 6.2 10.1 10.9 11.5 5.2 1.1 6.5 
4 0.0 0.0 0.0 0.0 0.2 2.2 11.4 12.2 1.9 5.4 0.2 0.0 0.0 
MT 0.4 0.3 0.1 0.0 1.4 1.3 0.8 2.1 2.2 1.7 0.9 0.1 1.7 
TIB, Time in bed; SPT, sleep period time; SE1, sleep efficiency index; SOL, sleep onset latency (time between lights off 
and first occurrence of stage 2, 3, 4 or REM). Night I of subject BIF could not be evaluated for technical reasons. 
" Night number. 
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brother (Brr2), as well as in their mother (B/M) and in their father (B/F), sleep was 
normal in all aspects. 
MSLT 
The results of the MSLT are summarized in Table 4. All members offarnily A showed 
shortened mean SOLs in comparison to normative data (16). The narcoleptic twin 
(Afrl) had four SOREMPs (REM latency between 0.5 and 4.0 min), and his sister (AlS) 
had one SOREMP (REM latency 7.0 min). In family B the narcoleptic twin showed a 
very short mean SOL and five SOREMPs (REM latency between 1.5 and 4.5 min), 
whereas his twin brothers and their parents' mean SOL was within normal limits. In 
B/M one SOREMP occurred (REM latency 9.5 min). In B/F two naps contained REM 
sleep (REM latency 15.5 and 12.0 min). 
DISCUSSION 
The results underline the important role of exogenous factors in the pathogenesis of 
narcolepsy/cataplexy. In both identical twin pairs investigated, only one twin presented 
clinical symptoms of the disease, and only in the afflicted one did the MSLT reveal 
mUltiple SOREMPs and short mean SOLs. The twins offamily A can be assumed to be 
discordant for narcolepsy, since it is very unlikely that the unaffected twin will develop 
the disease beyond the age of 50. In family B, on the other hand, the twins were only 
20 years old at the time of investigation. Thus, the unaffected twin is still at the age of 
risk and one cannot be sure that they will remain discordant. Nevertheless, one can 
assume that out of eight twins investigated up to now at least half of them were 
discordant. These data favor a multifactorial model for the pathogenesis of narcolepsy 
(4,5,17). In terms of this model, both the HLA DR2 or a nearly adjacent gene, and one 
or more exogenous factors are necessary to precipitate the disease. 
Nothing is known to date about the nature of possible exogenous factors necessary 
for the development of the illness. The strong association with HLA-DR2 suggests the 
involvement of autoimmunological processes. But there is no clear evidence pointing in 
this direction. Langdon et al. (18) reported two cases of increased cerebrospinal fluid 
(CSF) immunoglobulin concentrations and one with oligoclonal bands out of 20 pa-
tients investigated. Honda et al. (19) could not find abnormalities in different 
TABLE 4. Results of the Multiple Sleep Latency Test (MSLT) 
Subject mean SOL (min) range (min) SOREMPs (N) 
Family A 
A!fl 3.7 2.5-5.0 4 
A!f2 4.7 2.5-6.0 0 
NS 6.3 3.0-8.5 1 
Family B 
Bffl 2.4 1.0-3.5 5 
Brr2 10.4 4.0-20.0 0 
BIM 13.0 4.0-20.0 1 
B/F 11.0 8.0-16.0 1 
If a subject did not fall asleep during a session of the MSLT, a value of 20 
min was entered into the calculation of mean SOL; mean SOL is according to 
Carskadon et al. (16): time between lights off and fIrst occurrence of stage I, 
2, 3, 4 or REM; SOREMPs = number of Sleep onset REM periods. 
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lymphocyte subsets. On the other hand, in -10% of patients studied (18), the onset of 
the disease was in temporal relationship to an acute infection, as it was also at least in 
one of the cases reported here. Billiard et al. (20) reported significantly increased 
antibody titers to streptolysine 0 and DNase B in a group of 52 narcoleptic patients as 
compared with normal controls. However, control subjects were not matched for HLA-
DR antigens, and elevation of antibody titers was present in less than half of the 
patients. Possibly immunological mechanisms involved in the pathogenesis of narco-
lepsy are of very local character and/or oflimited duration and thus escape observation. 
SOREMPs are the most typical polygraphic abnormality found in narcolepsy. In 
addition, multiple SOREMPs during the MSLT in combination with short mean SOLs 
seem to be highly specific (21). Other polygraphic findings such as reduced slow wave 
sleep and disturbed night sleep are more variable and seem to be nonspecific. Our 
results support the assumption that SOREMPs are the most typical polygraphic char-
acteristic of narcolepsy, since in all other sleep parameters the twins investigated were 
much more similar to their respective healthy twin brother than to the other narcoleptic 
subject. 
There are some surprising findings in the asymptomatic relatives of the twins. In 
family A the healthy twin as well as the HLA identical sister of the twins showed short 
mean SOLs during the MSLT, which, according to normative data (16), would indicate 
excessive daytime sleepiness. The father of the twins in family B who was HLA DR2-
showed an unremarkable mean SOL during the MSLT, but one SOREMP and a second 
REM episode (REM latency 15.5 min) occurred. All these asymptomatic subjects re-
ported taking one or two naps almost every day. In the literature there are no conclu-
sive data on daytime sleep in relatives of narcoleptic subjects. In a preliminary report, 
Geisler et al. (22) could not find differences in night sleep or MSLT results between 
HLA DR2 + and HLA DR2 - first-degree relatives of narcoleptic patients. Two passing 
remarks concern the issue of sleep prospensity during the day: Mitler (14), in his review 
article on MSLT data, mentions two male offspring of a narcoleptic patient both show-
ing unremarkable night sleep, but short mean SOLs during the MSLT. In addition, one 
of them showed one SOREMP and the other three SOREMPs during the MSLT. HLA 
typing was not done in these subjects. Carskadon (23) followed a narcoleptic patients 
child who developed the disease at the age of 14. As early as 2 years before the onset 
of the disease the MSL T indicated that she was sleepier than controls. The latter finding 
suggests that the MSLT may help to identify subjects before the onset of narcolepsy 
who later on may develop the disease. Contrary to this assumption our results seem to 
indicate that in asymptomatic relatives of narcoleptics short mean SOLs or even mul-
tiple SOREMPs during the MSLT may be without clinical significance. In our inves-
tigation all subjects showing such results were beyond the main age of risk, and the 
subject showing one SOREMP, and in addition, a second REM episode with a latency 
of 15.5 min during the MSLT, was HLA DR2-. 
To get more information about possible premorbid polygraphic sleep patterns and 
their significance for the pathogenesis of narcolepsy, longitudinal studies of night sleep 
and MSLT in young asymptomatic relatives are needed. 
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